iShares U.S. Pharmaceuticals ETF
About
iShares U.S. Pharmaceuticals ETF (US4642888360) is a US-listed equity ETF tracking the Dow Jones U.S. Select Pharmaceuticals Index. With a expense ratio of 0.38%, it is moderately priced, paying distributions. The fund holds 60 positions across 1 region with 956M in assets, with heavy concentration — 100% in United States, 100% in Health Care.
Score Breakdown
Scores are scaled 1–10 on a logarithmic curve relative to all ETFs in the database. Last updated: Jun 22, 2026
| Component | Score | Details |
|---|---|---|
| Cost (30%) | 7.9 | Tracking Difference: 10.0 · TD Consistency: — · Expense Ratio: 3.0 |
| Liquidity (25%) | 8.1 | Assets Under Management |
Data sources: provider factsheets, exchange data, and NAV history. Information for educational purposes only — not investment advice.
Ticker IHE
ISIN
Fund Size $956.4M
Issuer iShares
Distribution Pays Distributions
Replication Physical
Inception May 2006
Base Currency USD
Index Dow Jones U.S. Select Pharmaceuticals Index
Asset Class Equities
Category Equity Sector
Costs
7.9 This fund has low total costs, with competitive tracking and expense ratios.
Expense Ratio0.00%
Expense Ratio0.00%
| Metric | Value |
|---|---|
| Expense Ratio | 0.38% |
Cumulative Returns
Performance across different time periods.
Year to Date+0.00%
1 Year+0.00%
3 Years+0.00%
5 Years+0.00%
Inception+0.00%
Year to Date+0.00%
1 Year+0.00%
3 Years+0.00%
5 Years+0.00%
Inception+0.00%
| Period | Cumulative Return |
|---|---|
| 1 Month | — |
| 3 Months | — |
| 6 Months | — |
| 1 Year | +43.63% |
| 3 Years | +19.02% |
| 5 Years | +10.26% |
| 10 Years | +8.15% |
| YTD | +8.58% |
| Since Inception | +10.49% |
Holdings
This fund invests into 60 individual investments.
View all holdings (50)
| # | Holding | Ticker | Weight |
|---|---|---|---|
| 1 | Eli Lilly & Co | LLY | 2199.76% |
| 2 | Johnson & Johnson | JNJ | 2179.09% |
| 3 | Pfizer Inc | PFE | 448.16% |
| 4 | Royalty Pharma PLC | RPRX | 442.07% |
| 5 | Bristol-Myers Squibb Co | BMY | 441.99% |
| 6 | Viatris Inc | VTRS | 441.09% |
| 7 | Zoetis Inc | ZTS | 440.65% |
| 8 | Merck & Co Inc | MRK | 435.14% |
| 9 | Jazz Pharmaceuticals PLC | JAZZ | 347.37% |
| 10 | Elanco Animal Health Inc | ELAN | 298.10% |
| 11 | Axsome Therapeutics Inc | AXSM | 266.84% |
| 12 | Corcept Therapeutics Inc | CORT | 188.15% |
| 13 | Ligand Pharmaceuticals Inc | LGND | 135.76% |
| 14 | Liquidia Corp | LQDA | 123.04% |
| 15 | Indivior Pharmaceuticals Inc | INDV | 115.07% |
| 16 | Crinetics Pharmaceuticals Inc | CRNX | 93.20% |
| 17 | Organon & Co | OGN | 86.91% |
| 18 | Amneal Pharmaceuticals Inc | AMRX | 68.82% |
| 19 | Edgewise Therapeutics Inc | EWTX | 68.32% |
| 20 | Definium Therapeutics Inc | DFTX | 65.80% |
| 21 | Supernus Pharmaceuticals Inc | SUPN | 63.48% |
| 22 | Tarsus Pharmaceuticals Inc | TARS | 61.61% |
| 23 | Prestige Consumer Healthcare Inc | PBH | 54.83% |
| 24 | Nektar Therapeutics | NKTR | 50.77% |
| 25 | Enliven Therapeutics Inc | ELVN | 50.77% |
| 26 | Trevi Therapeutics Inc | TRVI | 49.98% |
| 27 | Alumis Inc | ALMS | 49.13% |
| 28 | Ocular Therapeutix Inc | OCUL | 40.71% |
| 29 | Innoviva Inc | INVA | 38.86% |
| 30 | ANI Pharmaceuticals Inc | ANIP | 35.72% |
| 31 | VERADERMICS INC | MANE | 35.16% |
| 32 | Harrow Inc | HROW | 35.05% |
| 33 | Perrigo Co PLC | PRGO | 34.95% |
| 34 | Nuvation Bio Inc | NUVB | 33.40% |
| 35 | Harmony Biosciences Holdings Inc | HRMY | 32.76% |
| 36 | Amylyx Pharmaceuticals Inc | AMLX | 32.63% |
| 37 | Xeris Biopharma Holdings Inc | XERS | 29.57% |
| 38 | MBX Biosciences Inc | MBX | 28.26% |
| 39 | Collegium Pharmaceutical Inc | COLL | 26.81% |
| 40 | Rapport Therapeutics Inc | RAPP | 26.41% |
| 41 | EyePoint Inc | EYPT | 26.37% |
| 42 | WaVe Life Sciences Ltd | WVE | 23.07% |
| 43 | Pacira BioSciences Inc | PCRX | 21.65% |
| 44 | Septerna Inc | SEPN | 20.49% |
| 45 | AtaiBeckley Inc | ATAI | 19.52% |
| 46 | OMEROS CORP | OMER | 18.34% |
| 47 | LB Pharmaceuticals Inc | LBRX | 18.02% |
| 48 | MAZE THERAPEUTICS INC | MAZE | 17.86% |
| 49 | Phibro Animal Health Corp | PAHC | 16.54% |
| 50 | BIOAGE LABS INC | BIOA | 16.38% |
Sectors
Allocation by industry sector.
| Sector | Weight |
|---|---|
| Health Care | 9951.00% |
| Unknown | 49.00% |
Regions
Geographic allocation by country of risk.
| Country | Weight |
|---|---|
| United States | 9951.00% |
| UNKNOWN | 49.00% |
Similar ETFs
Other funds tracking Equity Sector indices.
iShares U.S. Technology ETF
IYW·Expense Ratio 0.38%
iShares Expanded Tech-Software Sector ETF
IGV·Expense Ratio 0.39%
iShares Expanded Tech Sector ETF
IGM·Expense Ratio 0.39%
iShares Global Tech ETF
IXN·Expense Ratio 0.39%
iShares Global REIT ETF
REET·Expense Ratio 0.14%
iShares U.S. Real Estate ETF
IYR·Expense Ratio 0.38%
Feedback
ETFs
Basket
Compare